H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Census population 577,222. Wisconsin Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Milwaukee clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Milwaukee storefront.
Biodynamic Hematogel Wound Care in Milwaukee, WI for clinics & physicians. Biodynamic hematogel achieves 9… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Obesity 41.8%; arthritis 23.8%. Those three PLACES crude rates (plus Census 577,222) are the local facts on this page. Everything else is the national biodynamic hematogel catalog and J6 paperwork.
National Biodynamic Hematogel Wound Care notes (how the product actually works)Three grains, kept separate on purpose. City: Census 577,222 and CDC PLACES crude rates. State: Wisconsin Department of Health Services, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and National Government Services (NGS) LCDs. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Milwaukee trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 14.7% of adults — 2.7 points above the U.S. 12% figure. Obesity is 41.8%; arthritis is 23.8%. That is place-level BRFSS modeling, not a clinic census and not a Milwaukee trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Bring specialty, monthly wound volume, and whether you bill J6 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.7% diabetes and 23.8% arthritis for Milwaukee — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Milwaukee, WI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Milwaukee is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Milwaukee — 2.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Wisconsin Part B wound biologics follow this contractor (siblings: IL, MN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Milwaukee. Useful for joint-program math; still needs a diagnosis and privileging.
No Milwaukee storefront. Joe Bradley is an active practice owner. biodynamic hematogel stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.